The molecular landscape of Fibrolamellar Hepatocellular Carcinoma (FLC), a rare liver cancer, remains to be characterised. Here, multi-omics analysis of liver tumours across different liver cancer subtypes identifies distinct transcriptomic signatures and reveals that PKA activation is the unifying phenotype of FLC.
- David Requena
- Jack A. Medico
- Sanford M. Simon
